期刊文献+

乳腺癌雌激素受体水平与MRI影像学表现的相关性研究 被引量:3

Correlation study of estrogen receptor and MRI morphological features for breast cancer
下载PDF
导出
摘要 介绍了乳腺癌雌激素受体(estrogen receptor,ER)表达状况与MRI表现如针刺样边缘、环形强化、时间-信号曲线(time-to-intensity curve,TIC)类型及表观扩散系数(analog-to-digital converter,ADC)间的关系,提出了不同ER表达状况的患者MRI特征性表现不同,其最主要的原因可能是ER表达阳性抑制新血管生成,通过影响病灶的纤维化及坏死程度、生长速度、灌注情况等,引起MRI形态学、强化形态、强化方式及弥散方面的差异。指出可以通过MRI动态增强的形态学表现及弥散加权成像的ADC值评估患者的激素水平,从而为临床精准评估乳腺癌预后及尽早制定诊疗方案提供更有价值的信息,亦为以后ER表达状况与TIC曲线类型的相关性研究提供指导。 The expression status of estrogen receptor(ER) and MRI features of breast cancer were introduced, which included needle-like edge, ring enhancement, types of time-to-intensity curve(TIC) as well as the relationship between ADC values. The breast cancer patients with expression statuses had different MRI features including MRI morphology,enhancement state, enhancement mode and diffusion, and the main cause was that ER positive expression suppressed neovascularization to influence the focal fibrosis, necrosis, growth rate, perfusion and etc. Hormone level was pointed out to be evaluated by morphological manifestations of MRI dynamic enhancement and ADC value of diffusion weighted imaging, so that valuable information could be provided for the prognosis evaluation, treatment planning as well as the studies on ER expression status and TIC types.
出处 《医疗卫生装备》 CAS 2017年第10期104-107,共4页 Chinese Medical Equipment Journal
基金 甘肃省自然科学基金(1606RJZA160)
关键词 乳腺癌 雌激素受体 MRI 表观扩散系数 时间-信号曲线 环形强化 breast cancer estrogen receptor MRI ADC TIC ring enhanced
  • 相关文献

参考文献2

二级参考文献17

  • 1陈蓉,龚水根,张伟国,陈金华,何双梧,刘宝华.乳腺癌和纤维腺瘤MR信号强度研究[J].中国医学影像技术,2003,19(6):670-673. 被引量:13
  • 2汪晓红,耿道颖,顾雅佳,彭卫军.乳腺恶性肿瘤的MRI表现及病理对照研究[J].中国医学计算机成像杂志,2005,11(2):100-106. 被引量:20
  • 3RM Mann, P Bult. Breast cancer size estimation with MRI in BRCA mutation carders and other high risk patients [ J ]. Eur J Radiology, 2013,82(9) : 1416-1422.
  • 4Janice S, Maxine S, Sandra Brennan, et al. MR Imaging Features of Triple-Negative Breast Cancers [ J ]. The Breast Journal,2013,11 (6) : 643 -649.
  • 5Riham H, E Khouli, Katar~na, et al. 3-T Dynamic Contrast-Enhanced MRI of the Breast:Pharmacokinetic Parameters Versus Conventional Kinetic Curve Analysis [ J ]. American Journal of Roentgenology, 2011,197 (6) : 1498-1505.
  • 6A Goldhirsch, EP Winer, AS Coates, et al. Personalizing the treatment of women with early breast cancer:highlights of the St Gallen Interna- tional Expert Consensus on the Primary Therapy of Early Breast Cancer [J]. Eur Soc Med Oncology,2013,24(9) :2206-2223.
  • 7Samantha L, Heller MD, Linda Moy MD, et al. Differentiation of malig- nant and benign breast lesions using magnetization transfer imaging and dynamic contrast-enhanced MRI [ J ]. Radiology, 2013,37 ( 1 ) : 138-145.
  • 8Mdadze NV, Temovo SK, Sharia MA, et al. Comprehensive magnetic resonance imaging for breast cancer [ J ]. Terapevticheski~arkhiv, 2013,85 (4) :29-33.
  • 9S Kul, A Cansu, E Alhan. Contribution of Diffusion-Weighted Imaging to Dynamic Contrast-Enhanced MRI in the Characterization of Breast Tumors [ J ]. American Journal of Roentgenology, 2011,196 ( 1 ) : 210-217.
  • 10范晓彧,杨军.乳腺浸润性导管癌的MRI诊断[J].放射学实践,2010,25(1):59-62. 被引量:15

共引文献8

同被引文献30

引证文献3

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部